Academic Journal
Q1Seminars in Liver Disease
About Seminars in Liver Disease
Seminars in Liver Disease is a scholarly journal published by Thieme Medical Publishers, Inc.. SCImago 2025 lists it in Q1, with an SJR of 1.45 and H-index of 146.
Coverage: 1981-2026. Research categories: Hepatology (Q1).
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Scope information will be added after verification.
Recent Research Articles
Latest publications matched automatically by ISSN.
Context-Dependent Roles of Liver Macrophages in MASH
Paul Horn, Frank Tacke
2026-09-15 · DOI: 10.1055/a-2954-5433Advances in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
Sunny Sandhu, Aparna Goel
2026-09-15 · DOI: 10.1055/a-2952-2261Expert Practical Recommendations for Portal Hypertension in Cirrhosis
Daniel Segna, Asunción Ojeda, Sonia Torres, Juan Carlos García-Pagán et al.
2026-09-24 · DOI: 10.1055/a-2956-4625Elevated Uric Acid and Metabolic Dysfunction—Associated Steatotic Liver Disease Progression: Where There's Smoke, is There Fire?
Eric E. Kelley, Owen M. Woodward, Nicholas K.H. Khoo
2026-08-21 · DOI: 10.1055/a-2926-5268Molecular Mechanisms of Progressive Familial Intrahepatic Cholestasis
Richa Gupta, Rodrigo M. Florentino, Amala Alenchery, Lara E. Berklite et al.
2026-08-21 · DOI: 10.1055/a-2933-3012Metabolic Dysfunction–Associated Steatotic Liver Disease Reprograms the Hepatic Metastatic Niche
Mustafa Karabicici, Ekihiro Seki
2026-08-04 · DOI: 10.1055/a-2921-0092Advances in Extracorporeal Liver Support
Kathryn Thompson, Hima Veeramachaneni, Ram Subramanian
2026-08-06 · DOI: 10.1055/a-2926-5335Toward Precision Medicine in MASLD: Evolution of Disease Subtyping
Ting Feng, Jiaming Li, Xiaoyi Ma, Junzhao Ye et al.
2026-08-07 · DOI: 10.1055/a-2926-5401MASH-Associated T Cell Activation and Neuroinflammation: Evidence for a Hepatosystemic Immune Axis
Britton S. Cartee, Fabiola Diniz, Ravi P. Rai, Pabitra B. Pal et al.
2026-07-23 · DOI: 10.1055/a-2908-1230Neutrophils in Liver Diseases: Functions and Challenging Therapies
Rui Ma, Haoran Meng, Xiutong Chen, Haiyuan Shen et al.
2026-04-24 · DOI: 10.1055/a-2847-3228Endothelial Cell Therapy for the Acute and Chronic Liver Disease
Dilnar Mahmut, Valerie Gouon-Evans
2026-03 · DOI: 10.1055/a-2841-9824Expert Practical Recommendations for Hepatocellular Carcinoma
Feng Su, Alejandro Torres-Hernandez, Ryan Hickey, Krishna Shanbhogue et al.
2026-03 · DOI: 10.1055/a-2832-4720Optimizing Liver Cancer Care Through BCLC Principles
Gemma Iserte, Neus Llarch, Andrew M. Moon, María Reig et al.
2026-03 · DOI: 10.1055/a-2769-7224Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates
Kelley Weinfurtner, Rudra Amin, Nicolas Skuli, Terence P. Gade et al.
2026-03 · DOI: 10.1055/a-2779-4984Practical Guide to Best Practices in Alcohol-Associated Liver Disease
Vinay Jahagirdar, Elina Stoffel, Kaanthi Rama, Alexandre Louvet et al.
2026-03 · DOI: 10.1055/a-2772-7248Hepatic Fibrosis and Liver Cancer
Aina Anton, Scott L. Friedman, Bruno Cogliati
2026-03 · DOI: 10.1055/a-2779-4937Nutrition and Liver Disease
Allison Franz, Henry Shay, Irina Kirpich, Craig J. McClain et al.
2026-03 · DOI: 10.1055/a-2725-5313Integrated Alcohol Use Disorder and Liver Disease Management
Hanna Blaney, Adelina Horhat, Abdulmalik Saleem, Gerald S. Winder et al.
2025-12 · DOI: 10.1055/a-2717-3496Reviews
Community Reviews
Version History
September 25, 2026 at 7:29 am
September 25, 2026